Broad spectrum mutational analysis of chromophobe renal cell carcinoma using next-generation sequencing

CONCLUSION: ChRCC is a rare disease still not fully molecularly characterized. Next-generation sequencing analysis could be useful to identify potential mutation with prognostic value or that could be potential therapeutic targets.PMID:33556910 | DOI:10.1016/j.prp.2021.153350

Source: Pathology, Research and Practice - February 8, 2021 Category: Pathology Authors: Veronica Mollica Tania Franceschini Elisa Gruppioni Alessandro Rizzo Costantino Ricci Riccardo Schiavina Eugenio Brunocilla Andrea Ardizzoni Michelangelo Fiorentino Francesca Giunchi Francesco Massari Source Type: research